Essel Dulaimi
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Epigenetics and DNA Methylation 13
- Renal and related cancers 12
-
- Renal cell carcinoma treatment 19
- Co-authors
- Tahseen Al‐Saleem (21 shared papers)Paul Cairns (13 shared papers)Robert G. Uzzo (31 shared papers)Inmaculada Ibañez de Cáceres (7 shared papers)Richard E. Greenberg (14 shared papers)Elizabeth R. Plimack (12 shared papers)Joseph R. Testa (17 shared papers)Gary R. Hudes (3 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)The Journal of Urology (6 papers)Cancer Research (4 papers)Clinical Cancer Research (4 papers)Blood (3 papers)
- Partner nations
- United StatesRussiaIreland
In The Last Decade
Essel Dulaimi
58 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 90
- Cancer Research 467
- Oncology 563
- Pulmonary and Respiratory Medicine 608
- Molecular Biology 1.2k
- Immunology 260
Countries citing papers authored by Essel Dulaimi
This map shows the geographic impact of Essel Dulaimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Essel Dulaimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Essel Dulaimi more than expected).
Fields of papers citing papers by Essel Dulaimi
This network shows the impact of papers produced by Essel Dulaimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Essel Dulaimi. The network helps show where Essel Dulaimi may publish in the future.
Co-authors
The 25 scholars most cited alongside Essel Dulaimi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 229 | |
| 2 | 2014 | 206 | |
| 3 | 2004 | 195 | |
| 4 | 2004 | 161 | |
| 5 | 2013 | 144 | |
| 6 | 2006 | 135 | |
| 7 | 2004 | 133 | |
| 8 | 2004 | 133 | |
| 9 | 2019 | 123 | |
| 10 | Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. | 2003 | 107 |
| 11 | 2019 | 93 | |
| 12 | 2017 | 84 | |
| 13 | 2012 | 70 | |
| 14 | 2019 | 64 | |
| 15 | 2019 | 58 | |
| 16 | 2020 | 56 | |
| 17 | 2021 | 53 | |
| 18 | 2014 | 49 | |
| 19 | 2004 | 48 | |
| 20 | 2013 | 45 |
About Essel Dulaimi
Essel Dulaimi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Surgery, having authored 59 papers that have together received 2.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (19 papers), Epigenetics and DNA Methylation (13 papers), Renal and related cancers (12 papers), Cancer Genomics and Diagnostics (9 papers), Bladder and Urothelial Cancer Treatments (8 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Cancer Research (467 citations), Oncology (563 citations), Pulmonary and Respiratory Medicine (608 citations), Molecular Biology (1.2k citations) and Immunology (260 citations). Essel Dulaimi has collaborated with scholars based in United States, Russia and Ireland. Frequent co-authors include Tahseen Al‐Saleem, Paul Cairns, Robert G. Uzzo, Inmaculada Ibañez de Cáceres, Richard E. Greenberg, Elizabeth R. Plimack, Joseph R. Testa, Gary R. Hudes, Alexander Kutikov and Kerry S. Campbell. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology, Cancer Research, Clinical Cancer Research and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.